Mark Hampton Harris, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 180 Parkwood Dr, Elkin, NC 28621 Phone: 336-527-7472 Fax: 336-835-8752 |
Steven Isaacs, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 Parkwood Dr, Elkin, NC 28621 Phone: 800-291-4020 Fax: 919-419-7247 |
Dr. Robert Everett Qualheim, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1321 N Bridge St, Elkin, NC 28621 Phone: 336-530-4491 Fax: 949-561-5143 |
John Kerry Collins, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 180 Parkwood Dr, Elkin, NC 28621 Phone: 800-291-4020 Fax: 919-419-7247 |
David Wiggins, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 Parkwood Dr, Elkin, NC 28621 Phone: 800-291-4020 Fax: 919-419-7247 |
James Tan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 180 Parkwood Dr, Elkin, NC 28621 Phone: 800-291-4020 Fax: 919-419-7247 |
Dr. Anna Wright, M.D. Emergency Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 Parkwood Dr, Elkin, NC 28621 Phone: 336-527-7217 |
News Archive
Last year, nearly 60 percent of Maine residents voted to expand the state's Medicaid program — an option provided by the Affordable Care Act that would extend health insurance to tens of thousands of the state's low-income people.
Cocrystal Discovery, Inc., a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases, announced today that it has received $733,438 in grants from the Qualified Therapeutic Discovery Project (QTDP) administered under section 48D of the Internal Revenue Code.
Over 1,000 children from Northern Ireland, Scotland, England and Wales, known as 'COVID Warriors' have had their antibodies measured in the UK-wide trial called 'Seroprevalence of SARS-Cov-2 infection in healthy children'.
"N60" might not be the first thing that comes to mind when people think of Alzheimer's disease, but thanks to researchers from the United States, South Korea and France, this might change. That's because these researchers have found that the N60 section of a protein called "RanBP9" might be the key that unlocks an entirely new class of Alzheimer's drugs, and with them, hope. In a research report published online in The FASEB Journal, these scientists describe how the N60 fragment of the RanBP9 protein increases the production of the amyloid beta protein, which is present in excessive amounts in the brains of people with Alzheimer's disease.
Two years ago, Beverlee London of Toronto was diagnosed with Stage I lung cancer. London was given the news by her lung specialist in Toronto that she had a malignant tumor on her right lung. She also decided at the time to visit the Barbara Ann Karmanos Cancer Center in Detroit for a second opinion, since she had family living in the area.
› Verified 2 days ago